Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Medulloblastoma 1

Interventions

Vincristine 4Platinum 4Cyclophosphamide 4Cisplatin 41,2-diaminocyclohexaneplatinum II citrate 4Radiotherapy 3Radiation 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3sodium thiosulfate 2Specimen Handling 2Metformin 2Magnetic Resonance Spectroscopy 2Lomustine 2Carboplatin 2merphos 1Thiotepa 1Tablets 1Stem Cell Transplantation 1Spinal Puncture 1Restraint, Physical 1Methotrexate 1Leucovorin 1Isotretinoin 1Hearing 1Fentanyl 1Evoked Potentials, Auditory, Brain Stem 1Etoposide 1Donepezil 1Cyproheptadine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Medulloblastoma × Hearing × Clear all
NCT05382338 2026-05-05

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Children's Oncology Group

Phase 3 Recruiting
225 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡